
Dangerous waters: What to know about the flesh-eating bacteria and brain-eating amoebas
Two waterborne pathogens have been increasing in freshwater lakes and brackish waters across the U.S. in recent years, due to the warming trends of climate change, according to the Centers for Disease Control and Prevention. The culprits are the rare "flesh-eating" bacteria (scientific name Vibrio vulnificus) and the "brain-eating" amoeba (scientific name Naegleria fowleri).
In early July, a boy died from the brain-eating amoeba, after swimming in a South Carolina lake. Four other people have died after contracting the rare flesh-eating bacteria in Florida this year, state health officials confirmed.
How do these pathogens enter the body?
The brain-eating amoeba and flesh-eating-bacteria are known to thrive in warm water environments.
The brain-eating amoebas are more commonly found in warm freshwater lakes and rivers, while the flesh-eating bacteria are primarily found in warm brackish water, which is a mix of fresh and salt water.
How both pathogens can enter the body during water activities:
Why is it called a brain-eating amoeba?
The amoeba is often referred to as brain-eating because it can cause an deadly infection called Primary Amebic Meningoencephalitis (PAM) that destroys brain tissue.
The brain-eating amoeba usually kills fewer than 10 Americans each year. In particular, only four survivors have been identified out of 167 instances that have been recorded in the U.S. between 1962 and 2024, according to the CDC.
Why is it called a flesh-eating bacteria?
The bacteria is often referred to as fleshing-eating because it can cause necrotizing fasciitis, which destroys muscle tissue, skin tissue and skin. It can enter through a cut, but it cannot penetrate unharmed skin. The bacteria can also enter your body when you eat uncooked or undercooked shellfish.
The flesh-eating bacteria is rare, but it can be life-threatening. Without treatment, death can occur in just a few days. An average of 150 to 200 cases are reported each year, with most of them in Gulf Coast states, according to the CDC.
Take these precautions during water activities
Swimmers, particularly those in southern states and warm coastal waters, should expect a minimal risk of contracting a pathogen in warm freshwater lakes, rivers, brackish waters and hot springs. How to lower your risks:
Medical experts always recommend keeping a close eye on children when they play or swim in the water. While it's uncommon for adults to swallow water while swimming, children are far more prone to do so, according to VCU Health.
Researchers are unsure why boys appear to be most at risk of being infected. It may be because they are more prone to play in the sediment at the bottom of lakes or jump and dive into the water, according to the CDC.
Progression of infection: Know the symptoms
Because of the life-threatening results, it is important to be know of symptoms and significance of seeking immediate medical assistance following any exposure. Here is a comparison of symptoms of the flesh-eating bacteria vs. the brain-eating amoeba:
CONTRIBUTING Julie Garisto, T. Sudore and C.A. Bridges/USA TODAY NETWORK, Christopher Cann and George Petras/USA TODAY
SOURCE Centers for Disease Control and Prevention, National Institute of Health, Cleveland Clinic, WebMD, VCU Health, The Florida Department of Health, Nature.com and USA TODAY research
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Post
3 minutes ago
- New York Post
Doctor exposes shocking disparity in medicine costs between the US and Australia
A doctor has exposed the shocking reality for Americans who are forced to pay up to tens of thousands of dollars for vital medicines that some Aussies fork out less than $10 for. Doctor Michael broke down the price discrepancies between five common medications in the United States, Australia and Scotland to his more than 500,000 followers on TikTok. Watched more than 2.7 million times, he started the video on a salbutamol inhaler, a puffer for asthma sufferers, costing about A$10, while it is US$50 in the states. A doctor has revealed the shock costs of five common medicines in the US, Australia and Scotland. One medication will set back Americans up to $84,500. 4 A doctor has revealed the shock costs of five common medicines in the US, Australia and Scotland. Nikish H/ – Atorvastatin, a medication to lower cholesterol and prevent cardiovascular disease, is priced as little as A$6.70 for 30 tablets in Australia, compared to US$2,628 for Americans. Next was Omeprazole, used for treating stomach acid, heartburn and reflux, costs A$6 in Australia and up to US $326 in the US. While Azithromycin, an antibiotic to treat bacterial infections, can set Americans back US$155, while many Aussies pay just A$7.70. However, the biggest shock was Sofosbuvir, which treats hepatitis C, with a 12-week treatment roughly costing an eyewatering US$84,000 without insurance and discounts. It equates to about US$1,000 a tablet, multiple US health websites reported. Meanwhile, it costs about $31 for a packet of 28 in Australia on the Pharmaceutical Benefits Scheme (PBS). Americans are facing much higher costs. There are no costs involved for all five medications mentioned in Scotland, Dr Michael said. 'Oh my god,' he said in reaction to the five-figure cost. 'See, in Scotland and Australia there's a socialist healthcare system which means that the government subsidises the cost of medications.' Commenters from around the world were left shocked. 'Aussie here, happy to pay extra tax to know that everyone can get medical care. It's a human right ffs,' one person said. 'America is one gigantic scam,' added another. 'People in Australia cry over tax we have to pay,' added a third. 'On the other hand, free hospitals, cheap medicine, cheap doctors, family tax benefit, aged care, unemployment benifits, aged pension, carer payments, meternity leave, farm house allowances, disability support, youth allowance. The list goes on. Australia looks after its citizens.' The medical practitioner's video came after President Donald Trump threatened a 200 percent tariff on imported drugs, one of Australia's largest exports to the US. 4 The medical practitioner's video came after President Donald Trump threatened a 200 per cent tariff on imported drugs, one of Australia's largest exports to the US. Tyler Olson – The commander-in-chief this week warned he may hike it a further 50 per cent. 'We'll be putting (an) initially small tariff on pharmaceuticals, but in one year, one-and-a-half years, maximum, it's going to go to 150 per cent,' he said in a CNBC interview on Tuesday. 'And then it's going to go to 250 per cent because we want pharmaceuticals made in our country.' Trump's fresh tariff threat It is feared President Trump's war on Big Pharma could have monumental consequences in Australia that could see billions wiped from the economy and the PBS caught in the crossfire. However, The Australian Institute's chief economist, Matt Grudnoff, urged caution and argued the leader of the free world himself was likely unsure of what he is going to do on pharmaceutical tariffs 'yet'. 'Some of the numbers he throws around, we know that even after well over six months now of talk about tariffs, he really hasn't nailed down exactly what they're going to be anywhere. This is something that I think will be off in the future,' Mr Grundoff told US President Donald Trump has threatened to slap 250 per cent tariffs on imported pharmaceuticals, a $2.2 billion export of Australia. He also stressed American consumers will be hit harder than Australians if any tariffs were to be applied, but Mr Grudnoff said the timing of it could be around the US midterms. 'If Trump imposes tariffs that increase the price of medicines in the US right before the midterm elections… I can't see that happening for political reasons if nothing else,' he said. 'I think that Republicans facing re-election will be very keen for that not to happen and also Trump has been… talking about decreasing medicine prices and (if) medicine prices go up, that might be quite difficult politically for him.' 4 He also stressed American consumers will be hit harder than Australians if any tariffs were to be applied, but Mr Grudnoff said the timing of it could be around the US midterms. bukhta79 – He said any levies on pharmaceuticals could have a 'slightly larger impact' compared to other industries and affect some of the largest medicine companies in Australia. The Albanese government ruled out making changes to the PBS to appease President Trump who has been urged to overhaul the 'discriminatory' scheme that 'undermines' US exports. Any alteration to the system may drive up prices of medicines in Australia. 'To be very clear, there seems to be very strong bipartisan policy in Australia (on) both sides that no, they're not going to use the PBS as a bargaining tool,' Mr Grudnoff said. 'There has been no indication yet that the Australian government would reduce pharmaceutical tariffs for higher US drug prices in Australia. I think they'd be crazy to do it. I don't think our trade with the US in pharmaceutical goods is anywhere near big enough to warrant the pain that would be caused in Australia by higher drug prices.' Both sides of government have ruled out any changes to the PBS amid President Trump's pharmaceutical tariff threat. Picture: NewsWire / Martin Ollman Prime Minister Anthony Albanese has previously said the PBS is 'not up for negotiation'. Last week the government introduced legislation to bring down the cap of eligible medicines on the PBS from $31.60 down to $25 from January 1 next year. Labor said it will save Australians about $200 million a year. PBS wait times a big concern, peak body warns The threat of President Trump's tariffs are less of a concern compared to the long wait times for medicines to be put on the PBS, a peak pharmaceutical research industry has said. Medicines Australia chief Liz de Somer warned Australians could die waiting for new life-saving medicines to be listed on the scheme Patients and advocacy groups say the complex process and excessive red tape involved is leading to unnecessary and long delays. 4 Patients and advocacy groups say the complex process and excessive red tape involved is leading to unnecessary and long delays. Tiktok/@drmichaelsays A report this week found the average wait time from when a medication is approved by the Therapeutic Goods Administration to being listed is 22 months. It would see drugs costing hundreds to thousands of dollars drop to just over $30. 'Patients will die waiting for medicines to be listed,' Ms de Somer said. 'And this will have a far greater effect on the Australian system than anything else.' A review of the PBS system was completed by the Health Technology Assessment and handed to the federal government last year, making a series of recommendations to improve speed. Health Minister Mark Butler has said the review will help guide the Albanese government on future decisions on reform. 'The Albanese government is continuing to make medicines available to Australian patients faster and cheaper,' he said. 'We know patients want faster access to cutting-edge medicine and treatments. 'That's why our government is working through the recommendations of the HTA review, so Australians can get faster access to the best medicines and therapies, at a cost that patients and the community can afford.'


The Hill
3 minutes ago
- The Hill
Congress wants to cut the smartest investment taxpayers ever made
Virtually every smartphone on the planet runs on a chip paid for by American taxpayers — a chip that I helped invent. Now Congress is moving to cut funding for the National Science Foundation that could lead to future breakthroughs. Investing in innovation is not wasteful spending. It is one of the smartest investments Washington makes, creating new jobs, stronger businesses and higher tax revenue in every corner of the country. Cutting the level of government funding for scientific research now would rip those future returns out of American hands and deliver them to our global competitors. I built my career in public universities. Over four decades, I helped lead a dozen federally funded research labs. Five of them produced breakthrough technologies that became part of the backbone of modern life. In the 1980s, we developed a much more efficient style of microprocessor (the RISC chip) in a university lab with graduate students funded by the government. At the time, few imagined that breakthrough would one day power 300 billion chips. The National Science Foundation also funded research that made digital storage much more reliable and affordable (called RAID storage), enhancing everything from cloud computing to online banking. These innovations helped launch entire industries and are used daily by billions of people. These breakthroughs did not come from corporate boardrooms or billionaire-backed startups. They were built by students, developed in public labs and funded by American taxpayers. For decades, my research received support from the NSF's Directorate for Computer and Information Science and Engineering, through grants and Ph.D. fellowships. All told, American taxpayers invested just under $100 million in the labs I helped lead. Accounting for inflation, technologies that came out of them went on to generate over $1 trillion in product sales. That is a 10,000-to-1 return on investment to the public and surely at least 1,000-to-1 return directly back to the government in taxes. Not from luck, but from decades of public investment. And the payoff is real. These gains show up as jobs in 44 states, tools that power small businesses and tax revenue that supports public schools, infrastructure and national defense. These returns belong to the American taxpayer. This isn't some ivory tower experiment or elite subsidy. It is an innovation engine and one of the most powerful drivers of U.S. economic strength. So what is Congress doing with one of the few federal programs that consistently creates value for everyday Americans? Preparing to cut National Science Foundation funding by $2 billion, a 23 percent reduction from 2025. The Trump administration has signaled that it wants to prioritize artificial intelligence, with efforts such as the recent AI Action Plan and the announcement of $100 million in NSF investment. These efforts can't begin to offset the damage of deep cuts to the broader ecosystem that makes future AI breakthroughs possible. Cutting the budget of the Directorate for Computer and Information Science and Engineering would be a self-inflicted blow to American competitiveness. Lawmakers say they're prioritizing programs with the greatest national impact, but this cut targets the very office funding the administration's top priorities: AI, quantum computing and cybersecurity. That's not prioritization. It's a fiduciary failure. AI is advancing fast, but it depends on breakthroughs throughout the computing stack. My own specialty, computer design, may seem distant from AI, but it's fundamental. Just look at NVIDIA's stock price. None of this appeared out of thin air. It came from researchers trained through NSF fellowships. Shrink the pipeline, and we lose the lead. Anticipating cuts, NSF has already halved its fellowships for 2025. We need more computer scientists, not fewer, and we need them trained here, not in countries eager to claim our place. China has more than tripled its research spending since 2010 and continues to raise it every year. China understands what is at stake: leadership in AI, semiconductors, cybersecurity and advanced computing. If we back off now, foreign firms will not hesitate to build on the breakthroughs that American taxpayers made possible. They will turn our investment in research into their dominance, and the jobs and industries that should grow in Atlanta, Boston and Dallas will take root in London, Bangalore and Shenzhen. As a scientist, I'm scared. As a taxpayer, I'm livid. We built a lead. Now Washington is ready to give it away. Since its founding, America has capitalized on innovation as the primary engine of wealth creation and nationwide prosperity. History is full of nations that failed to innovate and lost their edge. The U.S. has done the opposite. We invested in research, trained generations of scientists and engineers and built the most dynamic innovation ecosystem the world has ever seen. Every American taxpayer is a silent shareholder in that success. If we walk away now, we lose not just future breakthroughs but also what we have already earned. If Congress fails to preserve this funding, we hand our competitive edge and prosperity to someone else.


Newsweek
4 minutes ago
- Newsweek
Parent Asks Internet What Metal Pieces Are in Son's Bathroom, Answer Shocks
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A concerned parent has taken to Reddit to solve a puzzling mystery: what are the two small pieces of metal that keep appearing in their son's bathroom? In a now-viral post, user u/TrueReligion300 shared a photo showing the odd items on a black workout mat, captioning it with a note that they seem to find one or two of these metal bits every time they enter the room. The post quickly gained traction on the platform, gathering over 32,000 upvotes and attracting a flood of theories from users. While some speculated wildly, it was the top comment that delivered a straightforward and unexpected revelation—leaving the original poster stunned. "Now I feel stupid," the Reddit poster replied after learning the truth. A screenshot of the metal pieces shared on Reddit. A screenshot of the metal pieces shared on Reddit. Reddit/TrueReligion300 The mysterious items were identified as components from the tops of disposable lighters. As one Reddit user explained in the top comment, the pieces are "the smooth bit you run your thumb across on the flint roller. They're pulled out from the tops of lighters." Another user offered reassurance, saying: "Don't worry about it. Those of us who recognize it do so because we were delinquents when we were younger. Your son is either smoking or is a pyro [pyromaniac]. Take your pick." "I'd say he's a smoker," the parent wrote in a follow-up comment, though they added that they never smell nicotine on him. Others weighed in with possible explanations for the bathroom location. "Smoking in the bathroom with the steam shower going so the smoke dissipates," one user said, hinting at a possible way the teen may be masking the habit. The situation sparked broader discussions about teenage smoking. The Centers for Disease Control and Prevention (CDC) says that nearly 9 out of 10 adults who smoke cigarettes daily first tried smoking by age 18. In 2024, approximately 2 in 5 students who had ever used a tobacco product were still current users. Cigarette smoking remains a major public health concern, with more than 16 million Americans living with a smoking-related disease. Despite this, it is no longer the most pressing fear for parents of teenagers. A January 2023 Pew Research Center survey of 3,757 U.S. parents found that mental health now tops the list of concerns. Four-in-10 parents with children under 18 said they are extremely or very worried that their kids might struggle with anxiety or depression. This growing concern shows how emotional and psychological well-being has taken precedence in many families. Bullying is another significant worry, with 35 percent of parents expressing deep concern. These issues are seen as of greater urgency than more traditional dangers such as physical harm, substance use, teen pregnancy, or trouble with the police. Newsweek is waiting for u/TrueReligion300 to provide a comment.